The American Journal of Chinese Medicine,
Journal Year:
2024,
Volume and Issue:
52(08), P. 2403 - 2421
Published: Jan. 1, 2024
Cinnamon
is
one
of
the
world’s
oldest
and
most
popular
spices,
derived
from
inner
bark
several
tree
species
genus
Cinnamomum.
During
last
two
decades,
cinnamon
has
demonstrated
beneficial
metabolic
effects
not
only
in
animal
experiments
but
also
clinical
trials.
Even
recent
meta-analyses
have
shown
protective
on
different
components
syndrome
their
complications.
In
5
years,
experimental
studies
unraveled
intricate
molecular
mechanisms
underlying
antihypertensive,
antihyperglycemic,
lipid-lowering,
weight-lowering,
cardioprotective
properties
cinnamon.
This
review
paper
will
discuss
how
its
active
components,
particularly
cinnamaldehyde,
suppress
inflammation
oxidative
stress,
modulate
mitochondrial
dysfunction,
regulate
glucose
uptake,
insulin
resistance,
lipogenesis,
beta-oxidation,
Ca2+
signaling,
other
cellar
events
at
level.
Specifically,
we
delve
into
involved
to
provide
a
deeper
insight
can
bring
such
effects.
hopes
encourage
use
settings,
guide
combination
with
drugs
used
treat
based
mechanism
action,
support
concept
complementary
medicine
for
diseases.
Cardiovascular Therapeutics,
Journal Year:
2025,
Volume and Issue:
2025(1)
Published: Jan. 1, 2025
Purpose:
Myocardial
infarction
(MI),
a
severe
cardiovascular
disease,
is
the
result
of
insufficient
blood
supply
to
myocardium.
Despite
improvements
conventional
therapies,
new
approaches
are
needed
improve
outcome
post-MI.
Imperatorin
natural
compound
with
multiple
pharmacological
properties
and
potential
cardioprotective
effects.
Therefore,
this
work
investigated
imperatorin's
therapeutic
effects
its
mechanism
action
in
an
MI
mouse
model.
Methods:
Network
pharmacology,
molecular
docking,
experimental
validation
were
performed
for
exploring
pharmacokinetic
properties,
effects,
targets
imperatorin
MI.
Permanent
ligation
left
anterior
descending
artery
was
male
C57BL/6
mice
induce
before
treatment
once
per
day
1
week.
Echocardiography,
heart
histology,
RNA
sequencing,
quantitative
reverse
transcriptase
polymerase
chain
reaction
(qRT-PCR)
as
well
western
blotting
carried
out
evaluating
cardiac
function
structure,
gene
protein
expression.
Results:
significantly
improved
function,
preserved
attenuated
remodeling
fibrosis,
reduced
cardiomyocyte
apoptosis
mice.
Eight
differentially
expressed
genes
overlapping
key
target
found,
two
upregulated
six
downregulated.
A
signaling
pathways
associated
effect
angiotensin-converting
enzyme
(ACE).
inhibited
ACE-angiotensin
II
(Ang
II)-angiotensin
Type
receptor
(AT1R)
axis
Conclusion:
by
inhibiting
ACE-Ang
II-AT1R
axis.
Thus,
might
be
considered
agent
cure
Frontiers in Cardiovascular Medicine,
Journal Year:
2025,
Volume and Issue:
11
Published: Jan. 15, 2025
Myocardial
fibrosis
(MF)
is
a
common
pathological
manifestation
of
many
cardiovascular
diseases,
such
as
myocardial
infarction,
ischemia,
and
sudden
cardiac
death.
It
characterized
by
excessive
proliferation
activation
fibroblasts,
transformation
into
myofibroblasts,
and,
eventually,
deposition
the
extracellular
matrix,
resulting
in
heart
damage.
Currently,
modern
drugs
angiotensin-converting
enzyme
inhibitors,
diuretics,
β-blockers
can
improve
clinical
treatment,
but
their
therapeutic
effect
on
this
disease
limited,
with
obvious
side
effects
high
cost.
Traditional
Chinese
medicine
(TCM)
has
advantages
multiple
targets,
low
cost,
few
effects.
medicines,
Salvia
miltiorrhiza,
Astragalus,
Angelica
extracts,
patent
Qiliqiangxin
capsules,
Shenqi
Yiqi
dropping
pills,
Tongxinluo
fibrosis.
In
review,
current
Western
methods
for
treating
are
discussed.
The
signaling
pathways
targets
involved
treatment
This
review
aimed
to
provide
valuable
insights
ideas
both
basic
research
Ukrainian Journal of Cardiology,
Journal Year:
2025,
Volume and Issue:
32(1), P. 54 - 63
Published: Feb. 26, 2025
The
study
of
the
pathogenesis
and
pathomorphology
cardiofibrosis
can
be
reffered
to
one
important
problems
in
modern
cardiology.
This
review
paper
presents
data
on
different
stages
development
atrial
fibrillation
(AF).
Its
significant
advantage
lies
molecular
mechanisms
occurrence
disease
from
its
initial
final
stages.
It
has
been
established
that
a
number
activated
intracellular
signaling
pathways
profibrotic
factors
play
role
cardiofibrosis.
Their
interaction
leads
induction
progression
this
pathological
process.
work
also
includes
consistent
detailed
analysis
cytological
aspects
AF.
Important
conditions
cause
activation
fibroblasts
acceleration
fibrotic
process
are
changes
state
connective
tissue
cells,
cardiomyocytes
other
types
resident
heart
cells.
They
directly
involved
regulation
gene
expression
necessary
for
synthesis
specific
proteins
formation
fibrous
shown
proliferation
matrix,
inflammation,
oxidative
stress,
necrosis
cardiomyocytes,
fibrosis
remodeling
subsequently
observed
at
structural
histopathological
follow
period
functional
metabolic
disorders
atria
Thus,
it
should
expected
future
results
relevant
cardiological
studies
will
create
scientific
prerequisites
innovative
drugs
technologies.
allow
not
only
effectively
treat
patients
with
AF,
but
influence
processes
failure.
Reviews in Cardiovascular Medicine,
Journal Year:
2025,
Volume and Issue:
26(2)
Published: Feb. 21, 2025
Hypertrophic
cardiomyopathy
(HCM)
is
the
most
prevalent
hereditary
cardiovascular
disorder,
characterised
by
left
ventricular
hypertrophy
and
cardiac
fibrosis.
Cardiac
fibroblasts,
transformed
into
myofibroblasts,
play
a
crucial
role
in
development
of
However,
interactions
between
cardiomyocytes,
immune
cells
are
considered
major
mechanisms
driving
fibrosis
progression.
While
disease
has
strong
genetic
background,
its
pathogenetic
remain
complex
not
fully
understood.
Several
signalling
pathways
implicated
development.
Among
these,
transforming
growth
factor-beta
angiotensin
II
frequently
studied
context
In
this
review,
we
summarise
current
evidence
on
involvement
pathogenesis
HCM.
Additionally,
discuss
potential
monitoring
pro-fibrotic
molecules
predicting
clinical
outcomes
patients
with
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(6), P. 2667 - 2667
Published: March 16, 2025
Cardiovascular
disease
(CVD)
is
a
serious
global
health
issue
with
high
mortality
rates
worldwide.
Despite
the
numerous
advancements
in
study
of
CVD
pathogenesis
recent
years,
further
summarization
and
elaboration
specific
molecular
pathways
are
required.
An
extensive
body
research
has
been
conducted
to
elucidate
association
between
MAPK
signaling
pathway,
which
present
all
eukaryotic
organisms,
cardiovascular
disease.
This
review
aims
provide
comprehensive
summary
on
over
past
five
years.
The
primary
focus
four
diseases:
heart
failure,
atherosclerosis,
myocardial
ischemia–reperfusion
injury,
cardiac
hypertrophy.
will
also
address
pathophysiological
mechanisms
diseases,
objective
proposing
novel
clinical
treatment
strategies
for
CVD.
European Journal of Orthopaedic Surgery & Traumatology,
Journal Year:
2025,
Volume and Issue:
35(1)
Published: March 26, 2025
The
knee
joint,
one
of
the
most
vulnerable
joints
in
human
body,
is
susceptible
to
degenerative
changes
due
factors
such
as
aging,
obesity,
trauma,
inflammation,
and
genetic
predisposition.
These
contribute
primary
or
secondary
degeneration
joint
cartilage
bone
hyperplasia.
Knee
osteoarthritis
(KOA),
a
prevalent
condition
particularly
among
elderly,
significantly
impacts
patients'
quality
life.
Aberrant
activation
cellular
signaling
pathways,
namely
NF-κB,
MAPK,
Wnt
has
been
identified
key
factor
pathogenesis
KOA.
pathways
degradation,
disruption
anabolic-catabolic
balance
within
articular
cartilage.
Understanding
precise
roles
these
crucial
for
developing
targeted
therapies
prevent
treat
OA.
Therefore,
further
exploration
essential
develop
more
effective
therapeutic
strategies.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 2, 2025
Cardiovascular
disease
poses
a
significant
risk
to
human
health
and
remains
the
leading
cause
of
illness
death
globally,
with
its
incidence
continuing
rise.
The
intricate
pathophysiological
mechanisms
CVDs
include
inflammation,
oxidative
stress,
autophagy,
myocardial
fibrosis.
In
light
these
underlying
mechanisms,
traditional
Chinese
medicine
(TCM)
constituents
have
demonstrated
distinct
advantages
in
managing
CVDs.
By
exerting
synergistic
effects
across
multiple
components
targets,
can
modulate
inflammatory
response,
mitigate
regulate
excessive
enhance
fibrosis
repair.
This
article
reviews
latest
advancements
understanding
how
TCM
compounds
signaling
pathways
involved
treatment
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(8), P. 3550 - 3550
Published: April 10, 2025
This
study
systematically
elucidates
the
regulatory
mechanisms
and
potential
therapeutic
value
of
exercise-induced
hormone
Irisin
in
pathological
progression
cardiac
fibrosis.
Through
comprehensive
analysis
multidimensional
data
integration,
we
constructed
a
complete
network
within
cardiovascular
system,
spanning
its
secretion,
signal
transduction,
precise
control.
Our
findings
demonstrate
that
exercise
intervention
significantly
elevates
circulating
levels
via
skeletal
muscle–peroxisome
proliferator-activated
receptor
gamma
coactivator
1-alpha
(PGC-1α)–fibronectin
type
III
domain-containing
protein
5
(FNDC5)
signaling
axis.
establishes
molecular
barrier
against
fibrosis
by
targeting
Sirtuin
1
(Sirt1)
activation,
inhibiting
transforming
growth
factor-beta
(TGF-β)/Smad3
pathway,
modulating
transcriptional
activity
mitochondrial
biogenesis
core
factors
PGC-1α
nuclear
respiratory
factor
(NRF-1).
Moreover,
dual
mechanism
exercise–skeletal
muscle–heart
axis
not
only
effectively
suppresses
aberrant
activation
fibroblasts
but
also
reduces
collagen
deposition,
oxidative
stress,
inflammatory
infiltration
restoring
dynamics
balance.
Taken
together,
this
reveals
novel
exercise-mediated
cardioprotective
at
interaction
level,
thereby
providing
theoretical
basis
for
development
non-pharmacological
bio-intervention
strategies
pathway
laying
translational
foundation
prescriptions
diseases.